Skip to content

Evaluation of the A1CNow+ Test Kit

In-Clinic Evaluation of the Redwood A1c Test Kit With Lay-Users and Professionals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00798486
Enrollment
110
Registered
2008-11-26
Start date
2008-11-30
Completion date
2008-12-31
Last updated
2016-02-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes

Brief summary

The purpose of this study was to assure that consumers can successfully use the new version of A1CNow+ along with revised instructional materials.

Detailed description

The purpose of this study was to assure that consumers could successfully use the new version of A1CNow+ Test Kit along with revised instructional materials. The primary objective was to establish accuracy and secondary objectives were to establish precision, comprehension of instructional materials, and user feedback about the overall testing experience.

Interventions

DEVICEA1C Test Kit

Subjects tested 3 times with A1C test kits. Two tests were performed by the subject and the third test was performed by a healthcare professional (HCP). All results were compared to results from a laboratory glucose analyzer (TOSOH).

Sponsors

Ascensia Diabetes Care
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. Adults (age 18 and older) approximately 80% being ≤55 years old 2. Persons with: * known diabetes (type 1 or type 2) and pre-diabetes - approximately 85% of subject population per site * no known diagnosis of diabetes - approximately 15% of subject population per site 3. Individuals who are interested in performing a test using the kit at home 4. Individuals willing to complete all study procedures (including venous draw and allowing site staff to perform finger punctures) 5. Individuals who are able to speak, read, and understand English 6. Individuals able to read out loud the first 5 lines of the A1C Test Kit instructional materials to demonstrate ability to read the print (may use glasses, if needed)

Exclusion criteria

1. Individuals taking prescription anticoagulants (such as Warfarin or heparin) or have clotting problems that may prolong bleeding. (Taking Plavix or aspirin daily is not excluded) 2. Individuals with known Rheumatoid Arthritis or other condition causing significant impairment of manual dexterity 3. Individuals with a known hemoglobin variant such as HbS or HbC 4. Individuals with any known disorder of the blood or blood-forming organs (such as recovery from blood loss, hemolytic anemia, or iron deficiency anemia) 5. Individuals who have received a blood transfusion within the 4 months prior to the study. 6. Persons with known infection with a bloodborne pathogen (e.g. HIV, hepatitis) 7. Individuals working for a competitive medical device company 8. Individuals who have participated in previous studies on the A1CNow+ product 9. Persons missing a digit or partial digits on the hand 10. Individuals with the following impairments which, in the opinion of the investigator, would seriously compromise the integrity of the study: * Significant visual impairment * Significant hearing impairment * Cognitive disorder * Any other condition as per investigator's discretion

Design outcomes

Primary

MeasureTime frameDescription
Number of A1C Results Either Equal To Or Within +/- 13.5% of the Laboratory Method (ACCURACY)One hourThis outcome measure reports the number of A1c test results for which the percent difference (absolute value) between results from the subject meter and the laboratory method was less than or equal to 13.5%.

Secondary

MeasureTime frameDescription
Average Within Subject Coefficient of Variation CV (PRECISION)One hourThe average Coefficient of Variation (CV) was computed by calculating the square of the CV for each pair of A1c self-test results, averaging this square value over the number of subjects included in the analysis, and then taking the square root.
Percentage of Subjects Who Experienced First Time Failures (FTF) During TestingOne hourFor the comprehension analysis, subjects were divided into 2 groups. One group (n=56 subjects) was given both written (Quick Reference Guide) and DVD instruction material. The other group (n=54 subjects) was given only written instruction material. First time failure (FTF) was defined as: * The subject could not use the product without HCP assistance. * The subject could not complete the test. User error rendered one or more parts unusable. * The subject completed the test after one or more mistakes; the result was an error code instead of a numerical value.
Number of Participants Who Provided These Ratings For Overall Testing Experience With A1C Test KitOne hourSubjects rated features of the A1C Test Kit, including 'Overall Testing Experience'. The rating scale was 4 (Excellent) to 1 (Poor).

Countries

United States

Participant flow

Participants by arm

ArmCount
Subjects With and Without Diabetes
Subjects participating in this study included 93 who had diabetes and 17 who did not have diabetes.
110
Total110

Baseline characteristics

CharacteristicSubjects With and Without Diabetes
Age, Continuous46 years
Region of Enrollment
United States
110 participants
Sex: Female, Male
Female
40 Participants
Sex: Female, Male
Male
70 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 110
serious
Total, serious adverse events
0 / 110

Outcome results

Primary

Number of A1C Results Either Equal To Or Within +/- 13.5% of the Laboratory Method (ACCURACY)

This outcome measure reports the number of A1c test results for which the percent difference (absolute value) between results from the subject meter and the laboratory method was less than or equal to 13.5%.

Time frame: One hour

ArmMeasureGroupValue (NUMBER)
Subjects With and Without DiabetesNumber of A1C Results Either Equal To Or Within +/- 13.5% of the Laboratory Method (ACCURACY)Subjects had DVD and Written Instructions (n=101)94 number of A1c results
Subjects With and Without DiabetesNumber of A1C Results Either Equal To Or Within +/- 13.5% of the Laboratory Method (ACCURACY)Subjects had Written Instructions only (n=77)71 number of A1c results
Secondary

Average Within Subject Coefficient of Variation CV (PRECISION)

The average Coefficient of Variation (CV) was computed by calculating the square of the CV for each pair of A1c self-test results, averaging this square value over the number of subjects included in the analysis, and then taking the square root.

Time frame: One hour

Population: Precision Coefficient of Variation (CV)was analyzed using meter results from subject data that had numeric values for duplicate A1c self-tests. Subject data was not used in this outcome measure analysis when there had been a protocol deviation or when one (or both) A1c self-tests resulted in an error code.

ArmMeasureValue (NUMBER)
Subjects With and Without DiabetesAverage Within Subject Coefficient of Variation CV (PRECISION)4.57 average percentage CV
Secondary

Number of Participants Who Provided These Ratings For Overall Testing Experience With A1C Test Kit

Subjects rated features of the A1C Test Kit, including 'Overall Testing Experience'. The rating scale was 4 (Excellent) to 1 (Poor).

Time frame: One hour

ArmMeasureGroupValue (NUMBER)
Subjects With and Without DiabetesNumber of Participants Who Provided These Ratings For Overall Testing Experience With A1C Test Kit1 - Poor0 number of participants
Subjects With and Without DiabetesNumber of Participants Who Provided These Ratings For Overall Testing Experience With A1C Test Kit4 - Excellent65 number of participants
Subjects With and Without DiabetesNumber of Participants Who Provided These Ratings For Overall Testing Experience With A1C Test Kit3 - Very Good38 number of participants
Subjects With and Without DiabetesNumber of Participants Who Provided These Ratings For Overall Testing Experience With A1C Test Kit2 - Good7 number of participants
Secondary

Percentage of Subjects Who Experienced First Time Failures (FTF) During Testing

For the comprehension analysis, subjects were divided into 2 groups. One group (n=56 subjects) was given both written (Quick Reference Guide) and DVD instruction material. The other group (n=54 subjects) was given only written instruction material. First time failure (FTF) was defined as: * The subject could not use the product without HCP assistance. * The subject could not complete the test. User error rendered one or more parts unusable. * The subject completed the test after one or more mistakes; the result was an error code instead of a numerical value.

Time frame: One hour

ArmMeasureGroupValue (NUMBER)
Subjects With and Without DiabetesPercentage of Subjects Who Experienced First Time Failures (FTF) During TestingSubjects had DVD and Written Instructions11 percentage of subjects
Subjects With and Without DiabetesPercentage of Subjects Who Experienced First Time Failures (FTF) During TestingSubjects had Written Instructions Only40 percentage of subjects

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026